Great Lakes Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.1M Buy
192,181
+29,329
+18% +$1.68M 0.08% 140
2026
Q1
$9.88M Buy
162,852
+26,203
+19% +$1.53M 0.08% 150
2025
Q4
$7.37M Buy
136,649
+110,194
+417% +$5.3M 0.06% 183
2025
Q3
$1.19M Buy
26,455
+497
+2% +$23.2K 0.01% 511
2025
Q2
$1.2M Sell
25,958
-44,901
-63% -$2.2M 0.01% 499
2025
Q1
$4.32M Buy
70,859
+60,284
+570% +$3.51M 0.04% 302
2024
Q4
$598K Sell
10,575
-9,795
-48% -$547K 0.01% 637
2024
Q3
$1.05M Buy
20,370
+20,351
+107,111% +$955K 0.01% 578
2024
Q2
$789 Sell
19
-608,336
-100% -$27.2M ﹤0.01% 832
2024
Q1
$33M Sell
608,355
-652,234
-52% -$33.2M 0.28% 93
2023
Q4
$64.7M Sell
1,260,589
-457,616
-27% -$24M 0.62% 48
2023
Q3
$99.7M Buy
1,718,205
+482,199
+39% +$29.5M 0.91% 37
2023
Q2
$79M Sell
1,236,006
-180,838
-13% -$12.1M 0.79% 36
2023
Q1
$98.2M Buy
1,416,844
+1,354,019
+2,155% +$95.5M 0.89% 26
2022
Q4
$4.52M Buy
62,825
+56,109
+835% +$4.23M 0.26% 144
2022
Q3
$478K Buy
6,716
+2,884
+75% +$209K 0.01% 494
2022
Q2
$295K Buy
3,832
+209
+6% +$15.9K 0.01% 583
2022
Q1
$265K Sell
3,623
-1,435
-28% -$96.4K ﹤0.01% 624
2021
Q4
$316K Sell
5,058
-273
-5% -$16K ﹤0.01% 570
2021
Q3
$315K Sell
5,331
-485
-8% -$31.9K ﹤0.01% 580
2021
Q2
$389K Sell
5,816
-116
-2% -$7.56K 0.01% 550
2021
Q1
$374K Buy
5,932
+115
+2% +$7.16K 0.01% 546
2020
Q4
$360K Buy
5,817
+272
+5% +$16.7K 0.01% 523
2020
Q3
$334K Sell
5,545
-131
-2% -$7.88K 0.01% 485
2020
Q2
$333K Buy
5,676
+723
+15% +$43.2K 0.01% 480
2020
Q1
$276K Sell
4,953
-4,335
-47% -$265K 0.01% 484
2019
Q4
$596K Buy
9,288
+2,305
+33% +$132K 0.01% 424
2019
Q3
$354K Sell
6,983
-2,102
-23% -$98.8K 0.01% 472
2019
Q2
$412K Sell
9,085
-8,970
-50% -$418K 0.01% 460
2019
Q1
$861K Sell
18,055
-56,256
-76% -$2.8M 0.02% 409
2018
Q4
$3.86M Sell
74,311
-25,301
-25% -$1.36M 0.09% 231
2018
Q3
$6.18M Buy
99,612
+9,162
+10% +$544K 0.14% 157
2018
Q2
$5.01M Sell
90,450
-71,792
-44% -$3.88M 0.12% 193
2018
Q1
$10.3M Sell
162,242
-71,727
-31% -$4.61M 0.24% 92
2017
Q4
$14.3M Sell
233,969
-14,865
-6% -$930K 0.32% 59
2017
Q3
$15.9M Buy
248,834
+102,339
+70% +$5.98M 0.37% 48
2017
Q2
$8.16M Buy
146,495
+37,804
+35% +$2.06M 0.2% 89
2017
Q1
$5.91M Buy
108,691
+25,166
+30% +$1.38M 0.15% 115
2016
Q4
$4.88M Sell
83,525
-9,110
-10% -$498K 0.13% 133
2016
Q3
$5M Sell
92,635
-26,694
-22% -$1.71M 0.14% 121
2016
Q2
$8.78M Buy
119,329
+10,344
+9% +$731K 0.24% 72
2016
Q1
$6.96M Buy
108,985
+54,931
+102% +$3.46M 0.19% 89
2015
Q4
$3.72M Buy
54,054
+11,853
+28% +$783K 0.11% 165
2015
Q3
$2.5M Buy
42,201
+2,018
+5% +$128K 0.08% 215
2015
Q2
$2.67M Sell
40,183
-27,063
-40% -$1.78M 0.08% 198
2015
Q1
$4.34M Buy
67,246
+20,675
+44% +$1.29M 0.13% 125
2014
Q4
$2.75M Sell
46,571
-89
-0.2% -$5.02K 0.09% 172
2014
Q3
$2.39M Buy
46,660
+9,224
+25% +$461K 0.08% 177
2014
Q2
$1.82M Sell
37,436
-5,497
-13% -$271K 0.07% 136
2014
Q1
$2.23M Sell
42,933
-2,818
-6% -$150K 0.1% 129
2013
Q4
$2.43M Sell
45,751
-28,892
-39% -$1.47M 0.11% 85
2013
Q3
$3.45M Sell
74,643
-805
-1% -$35.3K 0.16% 86
2013
Q2
$3.37M Buy
+75,448
New +$3.28M 0.16% 82

Other funds holding BMY

Great Lakes Advisors's BMY Position: Q2 2026 in Review

Great Lakes Advisors increased its Bristol-Myers Squibb (BMY) stake by 18% in Q2 2026, buying an estimated $1.68M and bringing the position to 192,181 shares worth $11.1M. The position accounts for 0.08% of the portfolio, ranked #140.

Great Lakes Advisors first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $99.7M in Q3 2023. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Great Lakes Advisors held 192,181 shares of Bristol-Myers Squibb worth $11.1M as of Q2 2026.
  • Great Lakes Advisors bought 29,329 Bristol-Myers Squibb shares in Q2 2026, an estimated $1.68M.
  • Bristol-Myers Squibb made up 0.08% of Great Lakes Advisors's portfolio in Q2 2026, its #140 holding.
  • Great Lakes Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Great Lakes Advisors's Bristol-Myers Squibb position peaked at $99.7M in Q3 2023.
  • 2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Great Lakes Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.